05:26 PM EDT, 09/17/2024 (MT Newswires) -- A. Sinclair Dunlop, Director, on September 16, 2024, sold 37,000 shares in Apellis Pharmaceuticals ( APLS ) for $1,340,597. Following the Form 4 filing with the SEC, Dunlop has control over a total of 247,526 shares of the company, with 147,526 shares held directly and 100,000 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1492422/000095017024107411/xslF345X05/ownership.xml

Price: 37.01, Change: +1.48, Percent Change: +4.17